Autoantibodies in chronic hepatitis C virus infection and their association with disease profile

Journal of Viral Hepatitis

Volumn 16, Issue 5, 2009, Pages 325-331

  Williams, Mike J ^a   Lawson, A ^a   Neal, K R ^a   Ryder, S D ^a   Irving, W L ^a  

^a NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

Anti nuclear antibody; Anti smooth muscle antibody; Autoantibodies; Chronic hepatitis C; Interface hepatitis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; IMMUNOGLOBULIN; PEGINTERFERON; RIBAVIRIN; SMOOTH MUSCLE ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE ACTIVITY; FEMALE; HEPATITIS C; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALCOHOL DRINKING; ANTIBODIES, ANTINUCLEAR; AUTOANTIBODIES; CHILD; COHORT STUDIES; ETHNIC GROUPS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; MALE; MIDDLE AGED; MUSCLE, SMOOTH; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

EID: 63549143714     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/j.1365-2893.2008.01035.x     Document Type: Article

References (25)

1. Vergani D. NOSA in HCV infection: markers or makers of disease? Gut 1999 45 : 328 329.
2. Lenzi M, Bellentani S, Saccoccio G et al. Prevalence of non-organ-specific autoantibodies and chronic liver disease in the general population: a nested case-control study of the Dionysos cohort. Gut 1999 45 : 435 441.
3. Clifford BD, Donahue D, Smith L et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 1995 21 : 613 619.
4. Andersen P. Correlation of smooth-muscle and nuclear antibodies in normal subjects. Clin Exp Immunol 1977 27 : 74 77.
5. Muratori P, Muratori L, Marcello G et al. Clinical impact of non-organ-specific autoantibodies on the response to combined antiviral treatment in patients with hepatitis C. Clin Inf Dis 2005 40 : 501 507.
6. Bayraktar Y, Bayraktar M, Gurakar A, Hassanein TI, Van Thiel DH. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases. Hepatogastroenterology 1997 44 : 417 425.
7. Cassani F, Cataleta M, Valentini P et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology 1997 26 : 561 566.
8. Yee LJ, Kelleher P, Goldin RD et al. Antinuclear antibodies (ANA) in chronic hepatitis C virus infection: correlates of positivity and clinical relevance. J Viral Hepat 2004 11 : 459 464.
9. Squadrito G, Previti M, Lenzi M et al. High prevalence of non-organ-specific autoantibodies in hepatitis C virus-infected cirrhotic patients from southern Italy. Dig Dis Sci 2004 48 : 349 353.
10. Wasmuth HE, Stolte C, Geier A et al. The presence of non-organ-specific autoantibodies is associated with a negative response to combination therapy with interferon and ribavirin for chronic hepatitis C. BMC Infect Dis 2004 4 : 4.
11. Luo JC, Hwang SJ, Li CP et al. Clinical significance of serum auto-antibodies in Chinese patients with chronic hepatitis C: negative role of serum viral titre and genotype. J Gastroenterol Hepatol 1998 13 : 475 479.
12. Stroffolini T, Colloredo G, Gaeta GB et al. Does an 'autoimmune' profile affect the clinical profile of chronic hepatitis C? An Italian multicentre survey. J Viral Hepat 2004 11 : 257 262.
13. Mohsen AH on behalf of the Trent Hepatitis C Study Group. The epidemiology of hepatitis C in a UK health regional population of 5.12 million. Gut 2001 48 : 707 713.
14. Ryder SD on behalf of the Trent Hepatitis C Group. Progression of hepatic fibrosis in patients with hepatitis C: a prospective repeat liver biopsy study. Gut 2004 53 : 451 455.
15. Ishak K, Baptista A, Bianchi L et al. Histological grading and staging of chronic hepatitis. J Hepatol 1995 22 : 696 699.
16. Alvarez F, Berg PA, Bianchi FB et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999 3 : 929 938.
17. Dickson RC, Gaffey MJ, Ishitani MB, Roarty TP, Driscoll CJ, Caldwell SH. The international autoimmune hepatitis score in chronic hepatitis C. J Viral Hepat 1997 4 : 121 128.
18. Czaja AJ, Carpenter HA. Histological findings in chronic hepatitis C with autoimmune features. Hepatology 1997 26 : 459 466.
19. McCarthy M. The "gender gap" in autoimmune disease. Lancet 2000 356 : 1088.
20. Whitacre CC. Sex differences in autoimmune disease. Nat Immunol 2001 2 : 777 780.
21. Micallef JM, Kaldor JM, Dore GJ. Spontaneous viral clearance following acute hepatitis C infection: a systematic review of longitudinal studies. J Viral Hepat 2006 13 : 34 41.
22. Regev A, Berho M, Jeffers LJ et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastro 2002 97 : 2614.
23. Lagging LM, Westin J, Svensson E et al. Progression of fibrosis in untreated patients with hepatitis C virus infection. Liver 2002 22 : 136 144.
24. Simin M, Brok J, Stimac D, Gluud C, Gluud LL. Cochrane systematic review: pegylated interferon plus ribavirin vs. interferon plus ribavirin for chronic hepatitis C. Aliment Pharmacol Ther 2007 25 : 1153 1162.
25. Grimbert S, Johanet C, Bendjaballah F, Homberg JC, Poupon R, Beaugrand M. Antimitochondrial antibodies in patients with chronic hepatitis C. Liver 1996 16 : 161 165.